These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16170956)

  • 21. Relationship of severity of gastroesophageal reflux disease with gastric acid secretory profile and esophageal acid exposure during nocturnal acid breakthrough: a study using 24-h dual-channel pH-metry.
    Ghoshal UC; Chourasia D; Tripathi S; Misra A; Singh K
    Scand J Gastroenterol; 2008; 43(6):654-61. PubMed ID: 18569981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Precise role of acid in non-erosive reflux disease.
    Wang C; Hunt RH
    Digestion; 2008; 78 Suppl 1():31-41. PubMed ID: 18832838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn.
    Frazzoni M; Conigliaro R; Mirante VG; Melotti G
    Neurogastroenterol Motil; 2012 Feb; 24(2):141-6, e87. PubMed ID: 21988704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ambulatory 24-hour pH-metry in the diagnosis of gastroesophageal reflux disease. Determination of criteria and relation to endoscopy.
    Masclee AA; de Best AC; de Graaf R; Cluysenaer OJ; Jansen JB
    Scand J Gastroenterol; 1990 Mar; 25(3):225-30. PubMed ID: 2181620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acid and bile reflux in erosive reflux disease, non-erosive reflux disease and Barrett's esophagus.
    Hak NG; Mostafa M; Salah T; El-Hemaly M; Haleem M; Abd El-Raouf A; Hamdy E
    Hepatogastroenterology; 2008; 55(82-83):442-7. PubMed ID: 18613384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-erosive and erosive gastroesophageal reflux diseases: No difference with regard to reflux pattern and motility abnormalities.
    Martínek J; Benes M; Hucl T; Drastich P; Stirand P; Spicák J
    Scand J Gastroenterol; 2008; 43(7):794-800. PubMed ID: 18584517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring.
    Sharma N; Agrawal A; Freeman J; Vela MF; Castell D
    Clin Gastroenterol Hepatol; 2008 May; 6(5):521-4. PubMed ID: 18356117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of distribution of intraesophageal pH during nighttime recumbency among patients with gastroesophageal reflux disease.
    Hershcovici T; Jha LK; Fass R
    J Clin Gastroenterol; 2012 Aug; 46(7):562-6. PubMed ID: 22476040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathophysiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn.
    Frazzoni M; De Micheli E; Zentilin P; Savarino V
    Aliment Pharmacol Ther; 2004 Jul; 20(1):81-8. PubMed ID: 15225174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypersensitive esophagus: can it be classified as a subgroup of gastroesophageal reflux disease?
    Kuran SO; Dağli U; Alkim C; Oğuz D; Sahin B
    Turk J Gastroenterol; 2002 Mar; 13(1):24-30. PubMed ID: 16378270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional heartburn patients demonstrate traits of functional bowel disorder but lack a uniform increase of chemoreceptor sensitivity to acid.
    Shapiro M; Green C; Bautista JM; Peru RL; Malagon IB; Corvo M; Risner-Adler S; Beeler JN; Tuchinsky I; Fass R
    Am J Gastroenterol; 2006 May; 101(5):1084-91. PubMed ID: 16573776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastroesophageal reflux in patients with laryngeal disorders.
    Vanhemmens S; Wellens W; Tack J
    B-ENT; 2005; 1(3):117-23. PubMed ID: 16255496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring.
    Wiener GJ; Richter JE; Copper JB; Wu WC; Castell DO
    Am J Gastroenterol; 1988 Apr; 83(4):358-61. PubMed ID: 3348191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonerosive reflux disease.
    Long JD; Orlando RC
    Minerva Gastroenterol Dietol; 2007 Jun; 53(2):127-41. PubMed ID: 17557041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The time and pH at the moment of disappearance of pyrosis induced by of esophagus acid perfusion is an indicator of hyperalgesia].
    López Gastón AR
    Acta Gastroenterol Latinoam; 2000; 30(1):15-25. PubMed ID: 10855351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional heartburn and non-erosive reflux disease.
    Savarino V; Savarino E; Parodi A; Dulbecco P
    Dig Dis; 2007; 25(3):172-4. PubMed ID: 17827934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Barrier function of esophagogastric junction in patients with gastroesophageal reflux disease].
    Ding ZL; Wang ZF; Li HB; Sun XH; Xu L; Ke MY
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(34):2382-5. PubMed ID: 17156646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
    Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R
    Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients with functional heartburn are more likely to report retrosternal discomfort during wireless pH monitoring.
    Lee YC; Wang HP; Chiu HM; Huang SP; Tu CH; Wu MS; Lin JT
    Gastrointest Endosc; 2005 Dec; 62(6):834-41. PubMed ID: 16301022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.